Skip to main content

In recognition of Colon Cancer Awareness month, Cancer Connect hosted a webinar on March 16th. Join us as we take a closer look at how advancements in diagnostic testing are making it possible to detect recurrence earlier and assess treatment response better. 

Using ctDNA to Optimize Colorectal Cancer Management

  • What is a circulating tumor DNA test and how is it used to manage colorectal cancer?
  • How a tumor informed approach may provide additional insight to inform treatment decisions
  • Predicting relapse and identifying patients who may benefit from chemotherapy

The program was moderated by: John Strickler, M.D.

Scroll to Continue

Recommended Articles

Associate Professor of Medicine, Associate Director Clinical Research – GI Oncology, Co-Leader, Duke Cancer Institute Molecular Tumor Board, Duke University 

Colorectal Colon Rectal CancerConnect 490
Colorectal Colon Rectal Newsletter 490